Board member
Board of Directors
Targovax
Norway
er Samuelsson is a partner at Odlander Fredrikson/HealthCap, the life sciences venture capital firm, which he joined in 2000. Prior to this, Mr Samuelsson gained more than 15 years of investment banking experience, mainly with Aros Securities in Sweden. In his final position with Aros Securities, as a Director in the firm’s corporate finance department, Mr Samuelsson specialized in the areas of merger transactions, initial public offerings, and equity incentive programs. Prior to this, he was Head of Research, also at Aros Securities. Mr Samuelsson currently holds several Board positions at Nordic Nanovector ASA, NVC Holding AB, Oncopeptides AB, RSPR Pharma AB and SwedenBIO. He received his MSc in Engineering from the Institute of Technology in Linköping, Sweden. Mr Samuelsson is a Swedish citizen, and resides in Swede
merger transactions, initial public offerings, equity incentive programs ,investment banking